UNSPSC 51294001: Aprepitant

This classification denotes an antiemetic agent with the molecular formula C23H21F7N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1NF15YR6UY, chemically known as 3h-1,2,4-triazol-3-one, 5-(((2r,3s)-2-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro- but generally known as aprepitant, which bears US NIH Compound Identifier 151165. European Medicines Agency schedules Aprepitant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20017.

UNSPSC 51294001 Aprepitant is a Commodity code nominally for a specific antiemetic pharmaceutical, but recent state and local solicitations under this code show a significant mismatch with its abstract name. Seminole County, Florida posted an IFB in June 2026 seeking naloxone and drug deactivation systems—opioid-overdose reversal medication and harm-reduction equipment unrelated to aprepitant's therapeutic class. The code shows little relevant recent activity aligned with its stated pharmaceutical scope; the single opportunity on record appears to reflect either a data-entry error in the county's procurement classification or a broader misuse of the commodity code within Seminole County's system. State and local buyers should verify the actual product specification and therapeutic category before responding to opportunities posted under this code, as the posting may not accurately reflect the intended pharmaceutical procurement.

No additional recent opportunities under UNSPSC 51294001 are present in the available record to establish geographic spread, issuing-body concentration, or a pattern of legitimate pharmaceutical procurement activity. Business development professionals evaluating this code should treat it as dormant for standard aprepitant procurement and flag any new postings for manual verification against the stated scope of work before committing resources to pursuit.